BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
79 hedge funds and large institutions have $111M invested in BioSpecifics Technologies Corp. in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
2% more capital invested
Capital invested by funds: $109M → $111M (+$1.78M)
7% less funds holding
Funds holding: 85 → 79 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.53M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$1.46M |
| 3 |
Renaissance Technologies
New York
|
+$1.34M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$1.23M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$994K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$4.05M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.77M |
| 3 |
Morgan Stanley
New York
|
-$1.47M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.29M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.28M |
BSTC Hedge Fund Activity: Q1 2015 in Review
79 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2015, worth a combined $111M — up 1.6% from $109M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of BSTC and 6 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 33 added.
The largest buyer was Rice Hall James & Associates, adding an estimated $1.53M. The largest seller was Armistice Capital, exiting entirely with an estimated $4.05M sold.
- 79 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2015, down from 85 in Q4 2014.
- Funds reported $111M of BioSpecifics Technologies Corp. stock for Q1 2015, up 1.6% quarter-over-quarter.
- 6 funds opened new BioSpecifics Technologies Corp. positions in Q1 2015 and 12 closed out, a net change of -6 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q1 2015 was Rice Hall James & Associates, an estimated $1.53M added.
- The largest BioSpecifics Technologies Corp. seller in Q1 2015 was Armistice Capital, an estimated $4.05M sold.
Based on aggregated 13F filings for Q1 2015.